| General Information | |||
|---|---|---|---|
| Term | congenital myopathy 1A | ID (Ontology) | DOID:3529 (Human Disease) |
| Definition | A congenital myopathy that is characterized by muscle weakness primarily affecting the proximal muscles of the lower limbs beginning in infancy or early childhood, although later onset of symptoms has been reported and that has_material_basis_in heterozygous mutation in the ryanodine receptor-1 gene (RYR1) on chromosome 19q13. Heterozygous mutation in the RYR1 gene also causes susceptibility to malignant hyperthermia-1 (MHS1), patients with CMYP1A are at risk for MHS. Biallelic mutations in the RYR1 gene cause autosomal recessive CMYP1B, which shows overlapping features, but is typically more severe. | ||
| Also Known As | "autosomal dominant congenital myopathy 1A" ; "central core disease" ; "central core myopathy" | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
autosomal genetic disease |__autosomal dominant disease___ |__autosomal recessive disease__| myopathy | |__congenital myopathy__________| congenital myopathy 1A 1 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a |
autosomal dominant disease autosomal recessive disease congenital myopathy |
||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:6014 ICD10CM:G71.29 MESH:D020512 MIM:117000 NCI:C83010 ORDO:597 SNOMEDCT_US_2023_03_01:43152001 UMLS_CUI:C0751951 |
|||